John Rogers (Trades, Portfolio) Expands Investment in MSGS Ariel Investment, LLC, led by founder John Rogers (Trades, Portfolio), has recently increased its holdings in Madison Square Garden Sports Corp (NYSE:MSGS) by adding 946,982 shares to its portfolio. The transaction, which took place on December 31, 2023, at a trade price of $181.83 per share, reflects a strategic move by the firm to capitalize on the live sports and entertainment sector. With this addition, MSGS now represents 1.82% of the firm's portfolio, indicating a significant position with a 4.90% ownership stake in the company.
Steven Cohen (Trades, Portfolio), through Point72 Asset Management, has recently made a notable adjustment in the firm's investment portfolio by reducing its stake in Crinetics Pharmaceuticals Inc (NASDAQ:CRNX). This trade has altered the firm's portfolio by a -0.09% impact, with CRNX now representing 0.36% of the total portfolio and 5.10% of the firm's holdings in the traded stock.
Steven Cohen (Trades, Portfolio)'s Point72 Asset Management has recently made a notable addition to its investment portfolio by acquiring a significant number of shares in Cogent Biosciences Inc (NASDAQ:COGT). The firm now holds a 6.10% stake in Cogent Biosciences, representing 0.09% of its investment portfolio.
Strategic Portfolio Addition Glenn Greenberg (Trades, Portfolio)'s investment firm, Brave Warrior Advisors, has recently increased its investment in OneMain Holdings Inc (NYSE:OMF), a prominent player in the nonprime consumer finance sector in the United States. Following the trade, Brave Warrior Advisors holds a total of 6,416,800 shares in OneMain Holdings Inc, which represents 7.77% of the firm's portfolio and 5.36% of the company's outstanding shares. Glenn Greenberg (Trades, Portfolio)'s Investment Approach Glenn Greenberg (Trades, Portfolio), a notable figure in the investment community, co-founded Chieftain Capital Management in 1984 and later spearheaded Brave Warrior Advisors.
On February 14, 2024, Tiger Global Management, led by Chase Coleman (Trades, Portfolio), made a significant adjustment to its investment portfolio by reducing its stake in ATRenew Inc (NYSE:RERE). This move has altered the landscape of the guru's investment strategy, with ATRenew Inc now representing a 0.06% position in the portfolio, down from 0.09% previously, and the firm's ownership in the traded stock standing at 8.40%.